Medication info

New Ezytime Tablets (Ezetimibe)

Prescription medicationExpired
Ingredient · strength
Ezetimibe›Strength being verified
Manufacturer / importer
Anguk New Pharm Co., Ltd.
Appearance
White to almost white oblong tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Expired

MFDS item code 201801083 · Approved 2018.03.08

This product's status changed to Expired on 2023.03.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
Who uses it
Adults
Adult dosage
A standard cholesterol-lowering diet should be continued during treatment with this drug. The recommended dosage of this drug is 10 mg once daily, with or without food. When administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate this drug at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this drug concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this drug is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). Use in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Use in patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Use in older adults No dosage adjustment is necessary when administering this drug to older adults. Concomitant administration with bile acid sequestrants This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).

Ingredients

Manufacturer
Anguk New Pharm Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia

  • Primary hypercholesterolemia
  • elevated total cholesterol
  • elevated low-density lipoprotein cholesterol
  • elevated apolipoprotein B
  • mixed hyperlipidemia
  • elevated non-high-density lipoprotein cholesterol
  • homozygous familial hypercholesterolemia
  • elevated sitosterol
  • elevated campesterol
View approved original text

This medication helps to reduce total cholesterol and low-density lipoprotein cholesterol (LDL-C), commonly known as bad cholesterol, in patients with primary hypercholesterolemia. It is also applicable to patients with mixed hyperlipidemia and is used in conjunction with dietary measures. For the treatment of homozygous familial hypercholesterolemia, it is administered as an adjunct to other lipid-lowering therapies. Additionally, it helps reduce plant sterol levels in patients with homozygous sitosterolemia. This medication is used together with dietary therapy and is suitable in cases where non-drug measures are insufficient. Overall, this medication effectively improves the treatment of hypercholesterolemia and related dyslipidemic conditions.

Dosage and Administration

Adult dosage

A standard cholesterol-lowering diet should be continued during treatment with this drug. The recommended dosage of this drug is 10 mg once daily, with or without food. When administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate this drug at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this drug concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this drug is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). Use in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Use in patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Use in older adults No dosage adjustment is necessary when administering this drug to older adults. Concomitant administration with bile acid sequestrants This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).

Precautions

This medication should not be used in patients who are hypersensitive to any of its components. It is advisable not to use this medication together with certain types of drugs in patients with active liver disease or in those with a persistently elevated serum aminotransferase level without explanation. For women who are pregnant or breastfeeding, the combined use of this medication with certain lipid-lowering agents is prohibited, and caution is necessary for women of childbearing potential. Patients with severe liver dysfunction, biliary disease, or severe renal impairment should avoid concurrent use with certain lipid-lowering agents. Patients with moderate to severe liver dysfunction should be cautious in using this medication, as increased exposure may cause unexpected side effects. This medication generally has good tolerability; however, side effects such as headache, abdominal pain, diarrhea, fatigue, and myalgia may occur, so any unusual symptoms should be discussed with a physician. When this medication is used concurrently with certain lipid-lowering agents, liver enzyme levels may increase, so routine regular liver function tests are necessary. If muscle-related symptoms such as myalgia or weakness occur, notify medical personnel immediately, and in severe cases, discontinuation of the medication may be considered. Patients with impaired kidney function can also use this medication; however, caution is necessary in cases of severe renal impairment, but dose adjustment is not required. This medication may interact with other drugs, so it is essential to inform healthcare providers about any other medications being taken. Due to insufficient safety data for this medication during pregnancy or breastfeeding, consultations should be made with a doctor if pregnancy is planned or if pregnant. Use in children under 6 years is not recommended, and children and adolescents aged 6 and older should use it under a physician's direction. Elderly patients may also use this medication, but some may be more sensitive to the drug, so their condition should be monitored closely. In cases of overdose, immediate consultation with healthcare personnel is necessary, and appropriate treatment should be provided if needed. This medication should be stored out of reach of children, and it is safer not to transfer it to another container.

Side effects

  • Fatigue
  • abdominal pain
  • diarrhea
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • chest pain
Show 58 more
  • dizziness
  • headache
  • constipation
  • bloating
  • nausea
  • elevated AST
  • elevated ALT
  • myalgia
  • myopathy
  • rhabdomyolysis
  • increased liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • pancreatitis
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • chest discomfort
  • chest unease
  • edema
  • weakness
  • systemic edema
  • diabetic neuropathy
  • tremors
  • upper abdominal pain
  • vomiting
  • gastritis
  • dry mouth
  • epigastric discomfort
  • belching
  • gastrointestinal disorders
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • sputum
  • runny nose
  • limb pain
  • diabetes
  • hypoglycemia
  • anemia
  • splenomegaly
  • urticaria
  • hyperhidrosis
  • rash
  • pruritus
  • upper respiratory infection
  • conjunctival congestion
  • renal failure
  • abnormal liver function
  • elevated serum creatinine
  • increased blood pressure
  • increased blood urea
  • elevated serum creatine phosphokinase
  • abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is recommended to store it at room temperature, between 1 to 30 degrees Celsius. This helps maintain the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

White to almost white oblong tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.